Azacitidine for Treatment of Therapy Related Myelodysplastic Syndrome

被引：0
|
作者：
Komrokji, Rami S. [1 ]
Al Ali, Najla H. [1 ]
Alrawi, E. [1 ]
Padron, Eric [1 ]
Perkins, Janelle [2 ]
Field, Teresa [1 ]
Lancet, Jeffrey E. [1 ]
List, Alan F. [2 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：745 / 746
页数：2
相关论文
共 50 条
  • [41] A HEMODIALYSIS PATIENT WITH MYELODYSPLASTIC SYNDROME TREATED WITH AZACITIDINE
    Hiraga, Junji
    Nishimura, Hayato
    Kurata, Hisashi
    Kagami, Yoshitoyo
    ANNALS OF ONCOLOGY, 2014, 25
  • [42] Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
    Edlin, R.
    Connock, M.
    Tubeuf, S.
    Round, J.
    Fry-Smith, A.
    Hyde, C.
    Greenheld, W.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 69 - 74
  • [43] Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM)
    Bally, Cecile
    Thepot, Sylvain
    Quesnel, Bruno
    Vey, Norbert
    Dreyfus, Francois
    Fadlallah, Jehane
    Turlure, Pascal
    de Botton, Stephane
    Dartigeas, Caroline
    de Renzis, Benoit
    Itzykson, Raphael
    Fenaux, Pierre
    Ades, Lionel
    LEUKEMIA RESEARCH, 2013, 37 (06) : 637 - 640
  • [44] AZACITIDINE FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    Gritsaev, S., V
    Martynkevich, I. S.
    Kostroma, I. I.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2012, 57 (01): : 23 - 29
  • [45] MYELODYSPLASTIC SYNDROME. THERAPEUTIC ROLE OF AZACITIDINE
    Eguizabal Lorea, Arteche
    Ros Fernando, Marcotegui
    Moreno Fernando, Becerril
    Arnaiz Joana, Gonzalez
    ATENCION FARMACEUTICA, 2009, 11 (03): : 151 - +
  • [46] Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure
    Prebet, Thomas
    Gore, Steven D.
    Esterni, Benjamin
    Gardin, Claude
    Itzykson, Raphael
    Thepot, Sylvain
    Dreyfus, Francois
    Rauzy, Odile Beyne
    Recher, Christian
    Ades, Lionel
    Quesnel, Bruno
    Beach, C. L.
    Fenaux, Pierre
    Vey, Norbert
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3322 - 3327
  • [47] OUTCOME OF 5-AZACITIDINE AND DECITABINE TREATMENT IN ELDERLY PATIENTS WITH MYELODYSPLASTIC SYNDROME
    Nam, S.
    Lim, T.
    Kim, B.
    HAEMATOLOGICA, 2013, 98 : 588 - 588
  • [48] Outcome of 5-Azacitidine and Decitabine Treatment in Elderly Patients with Myelodysplastic Syndrome
    Nam, Seung-Hyun
    Lim, Taekyu
    Kim, Bong-Seog
    BLOOD, 2012, 120 (21)
  • [49] Poor Outcome of Patients with Myelodysplastic Syndrome (MDS) After Azacitidine Treatment Failure
    Lin, Karen
    Reljic, Tea
    Kumar, Ambuj
    Lancet, Jeffrey E.
    List, Alan F.
    Komrokji, Rami S.
    BLOOD, 2010, 116 (21) : 1199 - 1200
  • [50] Azacitidin Is Effective in the Therapy Related Myelodysplastic Syndrome
    Yamauchi, Hirofumi
    Yokoyama, Masahiro
    Mishima, Yuko
    Nishimura, Noriko
    Ueda, Kyoko
    Kusano, Yoshiharu
    Inoue, Norihito
    Takahashi, Anna
    Terui, Yasuhito
    Hatake, Kiyohiko
    BLOOD, 2016, 128 (22)
12345